FORTIS HEALTHCARE LTD. - 532843 - Certificate Under Regulation 40 (10) Of SEBI (Listing Regulations And Disclosure Requirements) Regulation, 2015
Pursuant to Regulation 40(9) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith a Certificate received from M/s. Mukesh Agarwal & Co., Company Secretaries, for the half-year ended on March 31, 2019. Kindly acknowledge receipt of the same. Fortis Healthcare remains a critical asset for IHH's global plans
Malaysian firm building team in Fortis even as there is status quo on the deal FORTIS HEALTHCARE LTD. - 532843 - Compliance Certificate- Regulation 7(3) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 - For Half Year Ended March 31, 2019
Pursuant to Regulation 7(3) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith Compliance Certificate certifying the compliance with the requirement of Regulation 7(2) for the half year ended March 31, 2019. You are requested to take the same on your record. FORTIS HEALTHCARE LTD. - 532843 - Statement Of Investor Complaints For The Quarter Ended March 2019
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 030300 Name of the Signatory :- Sumit GoelDesignation :- Company Secretary and Compliance Officer Fortis Healthcare looks to sell stake in Singapore-listed RHT trust
FHIL and Stellant are both wholly-owned subsidiaries of FHL FORTIS HEALTHCARE LTD. - 532843 - Reg. 30 - Intimation Made By RHTTM
With reference to the provisions of Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, it is hereby informed that RHT Health Trust Manager Pte. Ltd. (RHTTM), step down wholly owned subsidiary of Fortis Healthcare Limited (the Company or FHL), has made an intimation to Singapore Stock Exchange on April 7, 2019. A copy of the same has been attached herewith. This is for your information and records please. Fortis Healthcare Ltd - 532843 - Disclosure Under Regulation 30 - Change In CFO
This is in continuation of our letter ref. no. FHL/SEC/STEX/ 2018-19 dated February 13, 2019 captioned Outcome of the Board Meeting and with reference to the provisions of Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, please note that appointment of Mr. Vivek Kumar Goyal, Chief Financial Officer, is effective from April 8, 2019, consequently Mr. Girish Gupta will be stepping down as CFO with immediate effect. This is for your information and records please. FORTIS HEALTHCARE LTD. - 532843 - Announcement under Regulation 30 (LODR)-Credit Rating
Dear Sir(s), With reference to the provisions of Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, it is hereby informed that the Company has, today i.e. on April 3, 2019, received changes in credit ratings by 'CARE Ratings' in respect of the Company and Escorts Heart Institute and Research Centre Limited (subsidiary of the Company). The relevant reports made by CARE Ratings covering the rationale for revisions in the credit ratings are attached herewith. Fortis Healthcare Ltd - 532843 - Reg. 30 - Conversion Of Compulsorily Convertible Debentures Of Subsidiaries Of The Company
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that the Fortis Healthcare Limited (FHL or the Company) holds Compulsorily Convertible Debentures (CCDs), of Fortis Hospotel Limited (FHTL), of Escorts Heart and Super Speciality Hospital Limited (EHSSHL) and of International Hospitals Limited (IHL). The Company has, on March 29, 2019, approved the conversion of such CCDs into equity shares, in accordance with the terms of the relevant CCD agreements and provisions of applicable law. The detailed disclosure as required under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 is attached herewith as Annexure A. This is for your information and records please. Fortis Healthcare Ltd - 532843 - Reg. 30 - Conversion Of Compulsorily Convertible Debentures Of Subsidiaries Of The Company
With reference to the provisions of Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 and pursuant to provisions of Policy / Code of Conduct for Prevention of Insider Trading, the "Trading Window" for dealing in shares of the Company is closed from March 31, 2019 till further notice. This is for your information and records please.